Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

9,882 total articles

Insider Activity at Polaryx Therapeutics Highlights Strategic Investment Amid Drug Development Milestones

Insider Activity at Polaryx Therapeutics Highlights Strategic Investment Amid Drug Development Milestones

Polaryx Therapeutics, Inc. (PLYX) recently saw an insider stock purchase from Mstone Partners Healthcare Ltd. This transaction occurred on May 27, 2026, when Mstone acquired 88,453 shares of common stock at $4.07 per share, totaling $360,003. The acquisition represents a private placement generating gross proceeds of $360,000 for the company.This i…

Insider Buying at Nakamoto Inc.: CEO David Bailey Acquires Significant Shares Amid Corporate Developments

Insider Buying at Nakamoto Inc.: CEO David Bailey Acquires Significant Shares Amid Corporate Developments

Nakamoto Inc.'s Chief Executive Officer, David F. Bailey, recently acquired a substantial amount of the company's common stock through direct transactions reported to the SEC. This buying activity occurs as the stock has faced significant declines over both the past week and the last year. Furthermore, the company is undergoing several strategic ad…

Aurora Director Sells Significant Stock Stake Amid Market Volatility

Aurora Director Sells Significant Stock Stake Amid Market Volatility

Director Reid Hoffman recently conducted a significant sale of Aurora Innovation's (NASDAQ:AUR) common stock. The transaction involved the disposal of 1,202,354 shares on May 28, 2026, generating total proceeds of $8,746,043. This selling activity occurs against a backdrop of significant market movement for the autonomous driving company, whose sto…

Monte Rosa COO Jennifer Champoux Executes Stock Transactions Amid Company Milestones and Analyst Interest

Monte Rosa COO Jennifer Champoux Executes Stock Transactions Amid Company Milestones and Analyst Interest

Jennifer Champoux, Chief Operating Officer at Monte Rosa Therapeutics (GLUE), engaged in a stock sale totaling $43,500 on May 27, 2026. This transaction followed the utilization of pre-scheduled options under a Rule 10b5-1 trading plan. The report details the specifics of this executive activity alongside recent operational achievements for Monte R…

Unity CFO Yahes Sells Stock As Tax Withholding Obligation; Company Reports Q1 Results and Analyst Upgrades

Unity CFO Yahes Sells Stock As Tax Withholding Obligation; Company Reports Q1 Results and Analyst Upgrades

Jarrod Yahes, the Senior Vice President and Chief Financial Officer of Unity Software Inc., disposed of a significant block of common stock. This sale was explicitly linked to covering tax withholding obligations following the vesting of restricted stock units, rather than being a discretionary trade. Meanwhile, the company released its first quart…

Unity Software Insider Activity and Q1 2026 Performance Review

Unity Software Insider Activity and Q1 2026 Performance Review

Rebecca Berenice Boyden, SVP and Chief Legal Officer at Unity Software Inc., sold shares in a transaction related to tax withholding. This insider activity report is set against the backdrop of Unity's Q1 2026 financial results, which showed robust revenue growth despite slightly missing earnings per share forecasts.

Executive Sale and Analyst Sentiment at Acushnet Holdings

Executive Sale and Analyst Sentiment at Acushnet Holdings

Acushnet Holdings' President, Steven Francis Pelisek, recently sold a substantial block of company stock valued at $1,368,931. This transaction occurred as the company released its first-quarter 2026 results, which showed revenue exceeding expectations but earnings per share falling slightly below forecasts. Despite these mixed initial signals, maj…